NCT04784403View on ClinicalTrials.gov

SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDY

CompletedOBSERVATIONAL

Enrollment

3,356

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

February 24, 2021

Study Completion Date

February 24, 2021

Conditions

SARS-CoV-2 Infection

Interventions

DIAGNOSTIC_TEST

SARS-CoV-2 PCR and serology tests

Once the informed consent has been signed, the selected subjects must complete an epidemiological survey and go to a UB sample collection center to perform a PCR and serology test for SARS-CoV-2.

Trial Locations (1)

08907

Francisco Ciruela Alférez, L'Hospitalet de Llobregat

All Listed Sponsors

collaborator

Gerencia Territorial del Área Metropolitana Sur - Instituto Catalán de la Salud

UNKNOWN

collaborator

Hospital Universitario de Bellvitge

UNKNOWN

collaborator

Fundació IDIBELL

UNKNOWN

lead

Dr. Francisco Ciruela Alférez

OTHER

NCT04784403 - SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDY | Biotech Hunter | Biotech Hunter